| scholarly article | Q13442814 |
| P2093 | author name string | Majid Afshar | |
| Elizabeth Salisbury-Afshar | |||
| Perry Formanek | |||
| P2860 | cites work | Mobile phone-based interventions for smoking cessation | Q24185911 |
| Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation | Q24186545 | ||
| Motivational interviewing for smoking cessation | Q24187470 | ||
| Internet-based interventions for smoking cessation | Q24201266 | ||
| Physician advice for smoking cessation | Q24202663 | ||
| Pharmacological interventions for smoking cessation: an overview and network meta-analysis | Q24202961 | ||
| Nicotine replacement therapy for smoking cessation | Q24202991 | ||
| Interventions for preventing weight gain after smoking cessation | Q24203883 | ||
| The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
| A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Q27860879 | ||
| Metabolic effects of smoking cessation | Q28079736 | ||
| Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement | Q28267589 | ||
| E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis | Q28272129 | ||
| Electronic cigarettes for smoking cessation | Q28278571 | ||
| Stages and processes of self-change of smoking: toward an integrative model of change | Q29618719 | ||
| Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study | Q30776212 | ||
| Anxiety disorders in adults treated by hemodialysis: a single-center study | Q33331128 | ||
| National guidelines for smoking cessation in primary care: a literature review and evidence analysis | Q33697741 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 | ||
| Shape of the relapse curve and long-term abstinence among untreated smokers | Q34284019 | ||
| Stages of change and decisional balance for 12 problem behaviors | Q34340196 | ||
| Electronic cigarettes for smoking cessation: a randomised controlled trial | Q34370483 | ||
| Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial | Q34508532 | ||
| Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial | Q34523702 | ||
| Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers | Q34530493 | ||
| Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease | Q72639201 | ||
| Renal hemodynamic changes during smoking: effects of adrenoreceptor blockade | Q73231557 | ||
| Patient satisfaction and discussion of smoking cessation during clinical visits | Q73524403 | ||
| Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies | Q73873551 | ||
| Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction | Q73914894 | ||
| A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives | Q73924114 | ||
| Smoking--a renal risk factor | Q74260017 | ||
| Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers | Q77945795 | ||
| Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study | Q80414586 | ||
| Prevalence, harm perceptions, and reasons for using noncombustible tobacco products among current and former smokers | Q88065578 | ||
| Ten things that motivational interviewing is not. | Q34975443 | ||
| Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study | Q35118925 | ||
| Smoking cessation guidelines for health professionals: an update. Health Education Authority | Q35533569 | ||
| Acute effects of cigarette smoke on inflammation and oxidative stress: a review | Q35536904 | ||
| Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function | Q35611128 | ||
| A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report | Q35737760 | ||
| Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites | Q36024598 | ||
| Vascular disease, ESRD, and death: interpreting competing risk analyses | Q36294356 | ||
| Novel and reversible mechanisms of smoking-induced insulin resistance in humans | Q36410694 | ||
| Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial | Q36496852 | ||
| Depression in end-stage renal disease patients: a critical review | Q36955273 | ||
| Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. | Q36967592 | ||
| Cigarette smoking: an important renal risk factor - far beyond carcinogenesis | Q37165278 | ||
| Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial | Q37196970 | ||
| Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) | Q37201197 | ||
| Smoking cessation therapy considerations for patients with chronic kidney disease. | Q37265394 | ||
| Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. | Q37649417 | ||
| Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. | Q37682226 | ||
| The role of hypertension in the progression of renal diseases. | Q37711641 | ||
| Stages of change | Q37820944 | ||
| Psychological distress and depression in patients with chronic kidney disease | Q38027185 | ||
| Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study | Q38404067 | ||
| Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies | Q38740265 | ||
| Smoking cessation in patients with chronic kidney disease. | Q42750667 | ||
| Cigarette smoking and vascular pathology in renal biopsies | Q43889564 | ||
| Tobacco use screening and counseling during physician office visits among adults--National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005-2009. | Q43976522 | ||
| Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study | Q44044868 | ||
| Stopping smoking slows accelerated progression of renal failure in primary renal disease | Q44061119 | ||
| Triple-combination pharmacotherapy for medically ill smokers: a randomized trial | Q44321436 | ||
| Patients in context--EHR capture of social and behavioral determinants of health | Q44457645 | ||
| Associations between circulating inflammatory markers and residual renal function in CRF patients | Q44459462 | ||
| Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking | Q44469151 | ||
| Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. | Q44760582 | ||
| South African tobacco smoking cessation clinical practice guideline | Q46236162 | ||
| Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease | Q46521823 | ||
| Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and Women | Q47960312 | ||
| Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients. | Q50864875 | ||
| Blood pressure and end-stage renal disease in men | Q71574790 | ||
| Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study | Q71777734 | ||
| P577 | publication date | 2018-04-13 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking. |
Search more.